We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Standard Test May Miss UTI in Some Women

By LabMedica International staff writers
Posted on 18 May 2017
Print article
Image: A scanning electron microscope (SEM) image of Escherichia coli (E. coli) (Photo courtesy of NIAID).
Image: A scanning electron microscope (SEM) image of Escherichia coli (E. coli) (Photo courtesy of NIAID).
Urinary tract infection (UTI) is one of the most common infections that people experience. It arises when bacteria, most likely from the skin or rectum, enter the urethra and travel up to the bladder. UTIs affect several parts of the urinary tract, which includes the urethra, bladder, ureters, and kidneys. However, the most common type of UTI is a bladder infection, also known as cystitis.

The symptoms of UTI include experiencing a burning feeling during urination, or having frequent and intense urges to urinate, even when there is not much urine to pass. Females are more likely to be affected by UTIs than males because they have a shorter urethra that is closer to the anus, making it easier for bacteria to get into the urinary tract and cause infection.

Scientists at Ghent University Hospital and their colleagues compared urine samples from 220 women who went to see their doctor because they had symptoms of UTI, with those of 86 healthy women with no such symptoms. The urine samples underwent the standard culture test and were also tested with a more sensitive method called quantitative polymerase chain reaction (qPCR), which can detect minute amounts of bacterial DNA known to cause UTIs, including Escherichia coli and Staphylococcus saprophyticus.

The team found that in the symptomatic group, 178/220 (80.9%) of the urine cultures were positive for any uropathogen and 95.9% (211/220) were E. coli qPCR-positive. For the control group, cultures for E. coli and E. coli qPCR were positive in, respectively, 9/86 (10.5%) and 10/86 (11.6%). In the symptomatic group, qPCR yielded 19 positive samples for S. saprophyticus qPCR, one positive sample for Mycoplasma genitalium and one for Trichomonas vaginalis. However, the qPCR test detected E. coli in 95.9% of those samples, and S. saphrophyticus in 8.6%. When the two qPCR test results were combined, they showed that 98.2% of the symptomatic women had an infection.

Stefan Heytens, MD, the lead author of the study said, “This suggests that if a woman has these symptoms, she probably does have a UTI. Our findings support previous studies, which indicate that traditional testing may not be helpful in uncomplicated UTIs. However, traditional urine culture tests may still have a role to play if treatment fails or if there are signs and symptoms of a more complicated UTI.” The study was published on April 27, 2017, in the journal Clinical Microbiology and Infection.

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Sekisui Diagnostics UK Ltd.